Trial Details

COMPLETED
Basic Information
Clinical ID c314
Identifier NCT06785493
Trial Title The Clinical Efficacy and Influence Factors of Individualized Treatment of Ustekinumab in Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions IBD (Inflammatory Bowel Disease)
Interventions DRUG: Optimized Treatment (OPT)
Participant Information
Sponsor Second Affiliated Hospital of Wenzhou Medical University
City Zhejiang
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2020-07-01
Primary Completion Date 2024-07-31
Completion Date 2024-07-31